BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 946714)

  • 21. Effect of bromocriptine on serum hormones in acromegaly.
    Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
    Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of acromegaly with bromocriptine.
    Wang C; Chan V; Yeung RT
    Aust N Z J Med; 1979 Jun; 9(3):225-32. PubMed ID: 288387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic bromocriptine treatment and glucose intolerance in acromegaly.
    Popović V; Micić D; Nesović M; Djordjević P; Mićić J; Djurić DS
    Exp Clin Endocrinol; 1985 Jun; 85(3):351-7. PubMed ID: 3899685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bomocriptine treatment of patients with acromegaly resistant to conventional therapy.
    Pelkonen R; Ylikahri R; Karonen SL
    Clin Endocrinol (Oxf); 1980 Mar; 12(3):219-24. PubMed ID: 6993053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bromocriptine and glucose tolerance in acromegalics.
    Dolecek R; Kubis M; Sajnar J; Závada M
    Pharmatherapeutica; 1982; 3(2):100-6. PubMed ID: 7048336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment of acromegaly with bromocriptine.
    Wass JA; Thorner MO; Morris DV; Rees LH; Mason AS; Jones AE; Besser GM
    Br Med J; 1977 Apr; 1(6065):875-8. PubMed ID: 576843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests.
    Nortier JW; Croughs RJ; Thijssen JH; Schwarz F
    Clin Endocrinol (Oxf); 1984 May; 20(5):565-71. PubMed ID: 6744634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ergot alkaloids on growth hormone and prolactin secretion in humans.
    Silvestrini F; Liuzzi A; Chiodini PG
    Pharmacology; 1978; 16 Suppl 1():78-87. PubMed ID: 643905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of CB-154 therapy on the glucose tolerance, IRI and GH response to glucose administration in acromegaly.
    Demura R; Yamaguchi H; Demura H; Shizume K
    Endocrinol Jpn; 1978 Aug; 25(4):355-9. PubMed ID: 710371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.
    Liuzzi A; Chiodini PG; Botalla L; Silvestrini F; Müller EE
    J Clin Endocrinol Metab; 1974 Nov; 39(5):871-6. PubMed ID: 4214404
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutical effects of bromocriptine (CB 154) in 10 acromegalic subjects. Study of somatotrophic function and clinical survey (author's transl)].
    Fossati P; Asfour M; Brion-Brevan B; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA; Blacker C
    Ann Endocrinol (Paris); 1977; 38(4):291-301. PubMed ID: 332054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of small doses of bromocriptine (Parlodel) on the serum level of growth hormone in acromegaly].
    Gáspár L; László F
    Orv Hetil; 1980 May; 121(20):1179-82. PubMed ID: 7413200
    [No Abstract]   [Full Text] [Related]  

  • 33. Bromocriptine treatment in acromegaly: clinical and biochemical effects.
    Halse J; Haugen HN; Bohmer T
    Acta Endocrinol (Copenh); 1977 Nov; 86(3):464-72. PubMed ID: 335755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of parlodel on carbohydrate metabolism regulation in acromegaly].
    Molitvoslovova NN
    Sov Med; 1984; (1):24-9. PubMed ID: 6701649
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegaly.
    Dallabonzana D; Liuzzi A; Oppizzi G; Verde G; Chiodini PG; Dorow R; Horowski R
    J Endocrinol Invest; 1985 Apr; 8(2):147-51. PubMed ID: 4031381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromocriptine therapy in eleven patients with acromegaly.
    Lundin L; Ljunghall S; Wide L; Boström H
    Acta Endocrinol Suppl (Copenh); 1978; 216():207-16. PubMed ID: 347863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bromocriptine treatment of acromegaly.
    Thorner MO; Chait A; Aitken M; Benker G; Bloom SR; Mortimer CH; Sanders P; Mason AS; Besser GM
    Br Med J; 1975 Feb; 1(5953):299-303. PubMed ID: 1111790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reappraisal of bromocriptine treatment for acromegaly.
    Maneschi F
    Horm Res; 1980; 12(4):191-205. PubMed ID: 7390405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bromocriptine therapy in acromegaly. A long-term review of 35 cases.
    Sachdev Y; Gopal K; Garg VK
    Postgrad Med J; 1981 Apr; 57(666):210-6. PubMed ID: 7027229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No effect of treatment with sodium valproate on plasma growth hormone in bromocriptine unresponsive acromegaly.
    Nortier JW; Croughs RJ; Schwarz F; Thijssen JH
    Acta Endocrinol (Copenh); 1986 Feb; 111(2):162-4. PubMed ID: 3082095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.